Carcinoma of the head and neck in the HPV era

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 20, Issue 3, 2011, Pages 161-173

  Cardesa, A ^a   Nadal, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Carcinoma; Head and neck; Histological variants; HPV

Indexed keywords

COLLAGENASE 3; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GELATINASE A; INITIATION FACTOR 4E; MATRIX METALLOPROTEINASE 14; NUCLEAR PROTEIN; NUCLEAR PROTEIN IN TESTIS; PROTEIN P16; PROTEIN P51; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; UNCLASSIFIED DRUG; UVOMORULIN;

ACANTHYLOTIC SQUAMOUS CELL CARCINOMA; ADENOSQUAMOUS CARCINOMA; ALCOHOL CONSUMPTION; ALCOHOLISM; BASAL CELL CARCINOMA; CANCER CLASSIFICATION; CANCER GENETICS; CANCER GROWTH; CANCER PROGNOSIS; CANNABIS ADDICTION; DYSPLASIA; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINIZATION; KERATINOCYTE; LYMPHOEPITHELIOMA; NONHUMAN; ORAL SEXUAL CONTACT; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; REVIEW; SMOKING; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; VERRUCOUS CARCINOMA;

ADULT; AGED; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SMOKING;

EID: 84858634503     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (140)

1. Parkin DM, Bray F, Ferlay J, Pisani P Estimating the world cancer burden. Globocan: 2000, Int J Cancer. 2001;94:153.
2. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48:3282.
3. Barnes L, Tse LLY, Hunt JL, et al. Tumours of the hypopharynx, larynx and trachea: Introduction. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. WHO classification: head and neck tumours. Lyon: IARC; 2005. p. 111.
4. Westra WH. The changing face of head and neck cancer in the 21st century: The impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol. 2009;3:78.
5. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24.
6. French CA, Kutok JL, Faquin WC, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 2004;22:4135.
7. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence. An emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007;110:1429.
8. Cardesa A, Gale N, Nadal A, Zidar N. Squamous cell carcinoma In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. WHO classification: head and neck tumours. Lyon: IARC, 2005;118.
9. Roepman P, Wessels LFA, Ketelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nature Gen. 2005;37:182.
10. Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, RH Brakenhoff. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003;63:1727.
11. Nadal A, Cardesa A. Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch. 2003;442:1.
12. Brennan JA, Mao L, Hruban H, et al. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. N Engl J Med. 1995;332:429.
13. Nadal A, Campo E, Pinto J, et al. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors. J Pathol 1995;175:181.
14. Pfeifer GP, Denissenko MF, Olivier M, et al. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene. 2002;21:7435.
15. Waf1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx. J Pathol. 1997;183:156.
16. Yamaguchi K, Wu L, Caballero OL, et al. Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int J Cancer. 2000;86:684.
17. Hibi K, Trink B, Patturajan M, et al. AIS is an oncogene amplified in squamous cell carcinoma. PNAS. 2000;97:5462.
18. Kujan O, Oliver R, Roz L, et al. Fragile histidine triad expression in oral squamous cell carcinoma and in precursor lesions. Clin Can Res. 2006;12:6723.
19. Tomizava Y, Nakajima T, Kohno T, Saito R, Yamaguchi N, Yokota J. Clinicopathological significance of FHIT expression in stage I non-small lung carcinoma Cancer Res. 1998;58:5478.
20. MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinomas of the larynx. Oncogene. 1997;15:1445.
21. MTS1/CDK4I protein and mRNA expression is associated with gene alterations in squamous cell carcinoma of the larynx. Int J Cancer 1999;81:705.
22. Jares P, Fernández PL, Campo E, et al. PRAD-I/Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 1994;54:4813.
23. Nadal A, Jares P, Pinyol M, et al. Association of CDK4 and CCND1 mRNA overexpression in laryngeal squamous cell carcinomas occurs without CDK4 amplification. Virchows Arch. 2007;450:161.
24. Henriksson H, Baldetorp D, Borg A, et al. p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck. Acta Oncol. 2006;45:300.
25. Nathan C-A O, Amirghahari N, Abreo F, et al. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients. Clin Cancer Res. 2004;10:5820.
26. Nathan C-A O, Amirghahari N, Rong X, et al. Mamalian target of rapamycin inhibitors as possible adjuvant therapy for microscopic residual disease in head and neck squamous cell cancer. Cancer Res. 2007;67:2160.
27. Almadori G, Bussu F, Cadoni G, Galli J, Paludetti G, Maurizi M. Molecular markers in laryngeal squamous cell carcinoma: Towards an integrated clinicobilogical approach. Eur J Cancer. 2005;41:683.
28. Cazorla M, Hernandez L, Nadal A, et al. Colagenase-3 expression is associated with advanced local invasion in squamous cell carcinoma of the larynx. J Pathol. 1998;186:144.
29. Giaccone G. The potential of antiangiogenic therapy in non-small cell lung cancer. Clin Cancer Res. 2007;13:1961.
30. Vlachtsis K, Nikolaou A, Markou K, Fountzilas G, Daniilidis I. Clinical and molecular prognostic factors in operable laryngeal cancer. Eur J Otorhinolaryngol. 2005;262:890.
31. Gao L-f, Wen L-j Yu H, et al. Knockdown of Stat3 expression using RNAi inhibits growth of laryngeal tumors in vivo. Acta Pharmacol Sin. 2006;27:347.
32. Gillison ML, Koch WM, Cappone RB, Spafford M, Westra WH. Evidence for a causal association of human papolloma virus and a subset of head and neck cancers. J Nat Cancer Inst. 2000;92:709.
33. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papilloma virus and oropharyngeal carcinoma. N Engl J Med. 2007;356:1944.
34. Pilch BZ, Bouquot J, Thompson LDR. Squamous cell carcinoma: non-keratinizing. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. WHO classification: head and neck tumours. Lyon: IARC; 2005. p. 16.
35. Begum S, Cao D, Gillison M, Zahurak M, Westra WH. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res. 2003;9:6469.
36. Goldenberg D, Begum S, Westra WH, et al. Cystic lymph node metatastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck. 2008;30:898.
37. El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003;27:1463.
38. El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2005;29:1367.
39. Alos L, Moyano S, Nadal A, et al. Human papilloma viruses are identified in a subgroup of sinonasal squamous cell carcinomas with favourable outcome. Cancer. 2009;115:2071.
40. Jo VY, Mills SE, Stoler MH, Stelow EB. Papillary squamous cell carcinoma of the head and neck: frequent association with human papillonavirus infection and invasive carcinoma. Am J Surg Pathol. 2009;33:1720.
41. Begum S, Westra WH. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol. 2008;32:1044.
42. Maxwell JH, Kumar B, Feng FY, et al. HPV-positive/p16-positive/EBV- negative nasopharyngeal carcinoma in North Americans. Head and Neck. 2010;32:562.
43. Lewis JS, Thorstad WL, Chernock RD, et al. p16 positive oropharyngeal squamous cell carcinoma: an entity with favourable prognosis regardless of HPV status. Am J Surg Pathol. 2010;34:1088.
44. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366:704.
45. Hafkamp HC, Speel EJ, Haesevoets A, et al. A subset of head and neck squamous cell carcinomas exhibits integration of HPV-16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer. 2003;107:394.
46. Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM. Inverse relationship between human papillomavirus-16 and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2008;14:366.
47. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favourable prognosis. J Clin Oncol. 2006;24:736.
48. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261.
49. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of reaponse to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26:3128.
50. Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol. 2008;26:3138.
51. Smith EM, Ritchie JM, Summersgill KF et a. Age, sexual behaviour and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004;108:766.
52. Gillison ML, D'Souza G, Westra WH, et al. Distinct risk factor profiles for human papillomavirus-16 positive and negative, head and neck cancer. J Natl Cancer Inst. 2008;100:407.
53. McLemore MS, Haigentz M, Smith RV, et al. Head and neck squamous cell carcinomas in HIV-positive patients: a preliminary investigation of viral associations. Head and Neck Pathol. 2010;4:97.
54. Moyano S, Ordi J, Caballero M, et al. Laryngeal squamous cell carcinoma in HIV-positive patients: lack of association with HPV infection. HIV Medicine. 2009;10:634.
55. McCaffrey TV, Witte M, Ferguson MT. Verrucous carcinoma of the larynx. Ann Otol Rhinol Laryngol. 1998;107:391.
56. Koch BB, Trask DK, Hoffman HT, et al. National survey of head and neck verrucous carcinoma. Patterns of presentation, care, and outcome. Cancer 2001;92:110.
57. Fliss DM, Noble-Topham SE, McLachlin CM, et al. Laryngeal verrucous carcinoma: a clinicopathologic study and detection of human papillomavirus using polymerase chain reaction. Laryngoscope. 1994;104:146.
58. Orvidas LJ, Kerry DK, Lewis JE, Suman VJ. Verrucous carcinoma of the larynx. Head Neck. 1998;20:197.
59. Spiro RH. Verrucous carcinoma, then and now. Am J Surg. 1998;176:393.
60. Kolbusz RV, Goldberg LH Verrucous carcinoma of the oral cavity. Int J Dermatol. 1994;33:618.
61. Bryan RL, Bevan IS, Crocker J, et al. Detection of HPV 6 and 11 in tumors of the upper respiratory tract using the polymerase chain reaction. Clin Otolaryngol. 1990;15:177.
62. Johnson TL, Plieth DA, Crissman JD, Sarkar FH. HPV detection by polymerase chain reaction (PCR) in verrucous lesions of the upper aerodigestive tract. Mod Pathol. 1991;4:461.
63. Kasperbauer JL, O'Halloran GL, Espy MJ, Smith TF, Lewis JE. Polymerase chain reaction (PCR) identification of human papillomavirus (HPV) DNA in verrucous carcinoma of the larynx. Laryngoscope. 1993;103:416.
64. Cardesa A, Zidar N. Verrucous Carcinoma of the hypopharynx, larynx and trachea In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. WHO classification: head and neck tumours. Lyon: IARC; 2005. p. 122.
65. Cooper JR, Hellquist H, Michaels L. Image analysis in the discrimination of verrucous carcinoma and squamous papilloma. J Pathol. 1992;166:383.
66. Muro-Cacho CA, Anderson M, Cordero J, Munoz-Antonia T. Expression of transforming growth factor β type II receptors in head and neck squamous cell carcinoma. Clin Cancer Res. 1999;5:1234.
67. Medina JE, Dichtel W, Luna MA. Verrucous carcinoma of the head and neck. Arch Otolaryngol. 1984;110:437.
68. Luna MA, Tortoledo ME. Verrucous Carcinoma In: Gnepp DR, editor. Pathology of the head and neck. New York: Churchill Livingstone; 1988. p. 497.
69. Cardesa A, Zidar N, Alos L, et al. The kaiser's cancer revisited. Was Virchow totally wrong? Virchows Arch. 2011;458:649.
70. Cardesa A, Zidar N, Nadal A, Ereño C. Papillary squamous cell carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. WHO classification: head and neck tumours. Lyon: IARC; 2005. p. 126.
71. Crissman JD, Kessis T, Shah KV, et al. Squamous papillary neoplasia of the adult upper aerodigestive tract. Hum Pathol. 1988;19:1387.
72. Ereño C, Lopez JI, Sanchez JM, Bilbao FJ. Papillary squamous cell carcinoma of the larynx. J Laryngol Otol. 2001;115:164.
73. Ferlito A, Rinaldo A, Devaney KO, Putzi MT. Papillary squamous cell carcinoma versus verrucous squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 1999;108:318.
74. Suarez PA, Adler-Storthz K, Luna MA, El-Naggar AK, Abdul-Karim FW, Batsakis JG. Papillary squamous cell carcinoma of the upper aerodigestive tract: a clinicopathologic and molecular study. Head Neck. 2000;22:60.
75. Sugiyama M, Bhawal UK, Dohmen T, Ono S, Miyauchi M, Ishikawa T. Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:594.
76. Thompson LDR, Wenig BM, Heffner DK, Gnepp DR. Exophytic and papillary squamous cell carcinomas of the larynx: a clinicopathologic series of 104 cases. Otolaryngol Head Neck Surg. 1999;120:718.
77. Slootweg PJ, Richardson M. Squamous cell carcinoma of the upper aerodigestive system. In: Diagnostic surgical pathology of the head and neck, 2nd ed. Gnepp DR ed. Philadelphia: Saunders 2009;45.
78. Cardesa A, Zidar N. Spindle cell carcinoma In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. WHO classification: head and neck tumours. Leon: IARC; 2005. p. 127.
79. Lewis JE, Olsen KD, Sebo TJ. Spindle cell carcinoma of the larynx: review of 26 cases including DNA content and immunohistochemistry. Hum Pathol. 1997;28:664.
80. Thompson LDR, Wieneke JA, Miettinen M, Heffner DK. Spindle cell (sarcomatoid) carcinomas of the larynx: a clinicopathologic study of 187 cases. Am J Surg Pathol. 2002;26:153.
81. Gale N, Zidar N. Benign and potentially malignant lesions of the squamous epithelium and squamous cell carcinoma. In: Cardesa A, Slootweg PJ, editors. Pathology of the Head and Neck. Berlin: Springer; 2006. p. 16.
82. Guarino M, Tricomi P, Giordano F, Cristofori E. Sarcomatoid carcinomas: pathological and histopathogenetic consideratons. Pathology. 1996;28:298.
83. Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol. 1996;20:277.
84. Torenbeck R, Hermsen MAJA, Meijer GA, Baak JPA, Meijer CJLM. Analysis of comparative genomic hybridization of epithelial and spindle cell components in sarcomatoid carcinoma and carcinosarcoma: histogenetic aspects. J Pathol. 1999;189:338.
85. Olsen KD, Lewis JE, Suman VJ. Spindle cell carcinoma of the larynx and hypopharynx. Otolaryngol Head Neck Surg. 1997;116:47-52. (Pubitemid 27066554)
86. Thompson LDR, Wieneke JA, Miettinen M, Heffner DK. Spindle cell (sarcomatoid) carcinomas of the larynx: a clinicopathologic study of 187 cases. Am J Surg Pathol. 2002;26:153.
87. Zidar N, Gale N, Kojc N, et al. Cadherin-catenin complex and transcription factor Snail-1 in spindle cell carcinoma of the head and neck. Virchows Arch. 2008;453:267.
88. Kojc N, Zidar N, Gale N, et al. Transcription factors Snail, Slug, Twist and SIP1 in spindle cell carcinoma of the head and neck. Virchows Arch. 2009;454:549.
89. Zidar N, Boštjančič B, Gale N, et al. Downregulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classical and desmosomal cadherins in spindle cell carcinoma of the head and neck - hallmark of epithelial-mesenchymal transition. Human Pathol. 2011;42:482.
90. Cardesa A, Zidar N, Ereño C. Basaloid squamous cell carcinoma In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. WHO classification: head and neck tumours. Lyon: IARC; 2005. p. 124.
91. Wain SL, Kier R, Volmer RT, Bossen EH. Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx. Report of 10 cases. Hum Pathol. 1986;17:1158.
92. Luna MA, El Naggar A, Parichatikanond P, Weber RS, Batsakis JG. Basaloid squamous carcinoma of the upper aerodigestive tract. Clinicopathologic and DNA flow cytometric analysis. Cancer 1990;66:537.
93. Raslan WF, Barnes L, Krause JR, Contis F, Killeen R, Kapadia SB. Basaloid squamous cell carcinoma of the head and neck: a clinicopathologic and flow cytometric study of 10 new cases with review of the English literature. Am J Otolaryngol. 1994;15:204.
94. Barnes L, Ferlito A, Altavilla G, MacMillan C, Rinaldo A, Doglioni C. Basaloid squamous cell carcinoma of the head and neck: clinicopathologic features and differential diagnosis. Ann Otol Rhinol Laryngol. 1996;105:75.
95. Ereño C, Lopez JI, Sánchez JL, Toledo JD. Basaloid-squamous cell carcinoma of the larynx and hypopharynx. A clinicopathologic study of 7 cases. Pathol Res Pract. 1994;190:186.
96. Morice WG, Ferreiro JA. Distinction of basaloid squamous cell carcinoma from adenoid cystic and small cell undifferentiated carcinoma by immunohistochemistry. Hum Pathol. 1998;29:609.
97. Erdamar B, Suoglu Y, Sirin M, Karaty C, Katircioglu S, Kiyak E. Basaloid squamous cell carcinoma of the supraglottic larynx. Eur Arch Otorhinolaryngol. 2000;257:154.
98. Banks ER, Frierson HF, Mills SE, George E, Zarbo RJ, Swanson PE. Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases. Am J Surg Pathol. 1992;16:939.
99. Paulino AFG, Singh B, Shah JP, Huvos AG. Basaloid squamous cell carcinoma of the head and neck. Laryngoscope. 2000;110:1479.
100. Ferlito A, Altavilla G, Rinaldo A, Doglioni C. Basaloid squamous cell carcinoma of the larynx and hypopharynx. Ann Otol Rhinol Laryngol. 1997;106:1024.
101. Cardesa A, Zidar N, Alos L. Adenosquamous carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. WHO classification: head and neck tumours. Lyon: IARC; 2005. p. 130.
102. Keelawat S, Liu CZ, Roehm PC, Barnes L. Adenosquamous carcinoma of the upper aerodigestive tract: a clinicopathologic study of 12 cases and review of the literature. Am J Otolaryngol. 2002;23:160.
103. Pera M, Cardesa A, Bombí JA, Ernst H, Pera C, Mohr F. Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous Injection of 2,6- Dimethylnitrosomorpholine. Cancer Research. 1989;49:6803.
104. Cardesa A, Bombí JA, Pera M, et al. Spectrum of glandular differentiation in experimental carcinoma of the esophagus induced by 2,6-dimethylnitrosomorpholine under the influence of esophagojejunostomy. Exp Toxic Pathol. 1994;46:41.
105. Pera M, Pera M, de Bolos C, et al. Duodenal-content reflux into the esophagus leads to expression of Cdx2 and Muc2 in areas of squamous epithelium in rats. J Gastrointest Surg. 2007;11:869.
106. Masand RP, El-Molly SK, Ma X-J, et al. Adenosquamous carcinoma of the head and neck: Relationship to human papilloma virus and review of the literature. Head and Neck Pathol. 2011;5:108.
107. Alos L, Castillo M, Nadal A, et al. Adenosquamous carcinoma of the head and neck: criteria for diagnosis in an study of 12 cases. Histopathology. 2004;44:570.
108. Fujino K, Ito J, Kanaji H, Shiomi Y, Saiga T. Adenosquamous carcinoma of the larynx. Am J Otolaryngol. 1995;16:115.
109. Gerughty RM, Hennigar GR, Brown FM. Adenosquamous carcinoma of the nasal, oral and laryngeal cavities: a clinicopathologic survey of ten cases. Cancer. 1968;22:1140.
110. Ereño C, Lopez JI, Bilbao FJ. The biphasic pattern of laryngeal and hypopharyngeal adenosquamous carcinoma is retained in lymph node metastases. Histopathology. 2005;46:715.
111. Alos, L, Lujan B, Castillo M, et al. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol. 2005;29:806.
112. Cardesa A, Zidar N, Alos L. Acantholytic squamous cell carcinoma. In: Barnes L, Eveson JW, Reichart Sidransky D, editors. WHO classification: head and neck tumours. Lyon: IARC; 2005. p. 129.
113. Nappi O, Pettinato O, Wick MR. Adenoid (acantholytic) squamous cell carcinoma of the skin. J Cutan Pathol. 1989;16:114.
114. Nappi O, Wick MR, Pettinato G, Ghiselli RW, Swanson FE. Pseudovascular adenoid squamous cell carcinoma of the skin. A neoplasm that may be mistaken for angiosarcoma. Am J Surg Pathol. 1992;16:429.
115. Zaatari GS, Santoianni RA. Adenoid squamous cell carcinoma of the nasopharynx and neck region. Arch Pathol Lab Med. 1986;110:542.
116. Gale N, Zidar N. Benign and potentially malignant lesions of the squamous epithelium and squamous cell carcinoma. In: Cardesa A, Slootweg PJ, editors. Pathology of the Head and Neck. Berlin: Springer; 2006. p. 22.
117. Tsang WYW, Chan JKC. Lymphoepithelial carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. WHO classification: head and neck tumours. Lyon: IARC; 2005. p. 130.
118. Dray T, Vargas H, Weidner N, Sofferman RA. Lymphoepitheliomas of the laryngohypopharynx. Am J Otolaryngol. 1998;19:263.
119. MacMillan C, Kapadia SB, Finkelstein SD, Nalesnik MA, Barnes L. Lymphoepithelial carcinoma of larynx and hypopharynx: study of eight cases with relationship to Epstein-Barr virus and p53 gene alterations, and review of the literature. Hum Pathol. 1996;27:1172.
120. Marioni G, Mariuzzi L, Gaio E, Pantaleone S, Pertoldi B, Staffieri A. Lymphoepithelial carcinoma of the larynx. Acta Otolaryngol. 2002;122:429.
121. Weiss LM, Movahed LA, Butler AE, et al. Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr viral genomes by in situ hybridization. Am J Surg Pathol. 1989;13:625.
122. Shingi MD, Stelow BE, Mills SE, Westra WH. Lymphoepithelial-like carcinoma of the oropharynx. A morphologic variant of HPV-related head and neck carcinoma. Am J Surg Pathol. 2010;34:800.
123. French CA, Miyoshi I, Aster JC, et al. BDR4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15; 19). Am J Pathol. 2001;459:1987.
124. French CA, Miyoshi I, Kubonishi I, et al. BDR4-NUT fusion oncogenc: a novel mechanism in aggressive carcinoma. Cancer Res. 2003;63:304.
125. Yu J, Croyle JR, Nishimura A, et al. Interaction of the bovine papillomavirus E2 protein with the Brd4 tethers the viral DNA to host mitotic chromosomes. Cell. 2001;117:349.
126. Stelow EB, Bellizzi AM, Taneja K, et al. NUT rearrangement in undifferentiated carcinoma of the upper aerodiagestive tract. Am J Surg Pahol. 2008;32:828.
127. Vargas SO, French CA, Faul PN, et al. Upper respiratory tract carcinoma with chromosomal translocation 15;19: evidence for a distinct disease entity of young patients with a rapidly fatal course. Cancer. 2001;92:1195.
128. Stelow EB. A review of NUT midline carcinoma. Head and Neck Pathol. 2011;5:31.
129. Shanmugaratnan K, Barnes L, Cardesa A, et al. WHO histological typing of tumours of the upper respiratory tract and ear. Berlin: Springer 1991.
130. Gale N, Pilch BZ, Sidransky D, Westra WH, Califano J. Epithelial precursor lesions. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. WHO classification: head and neck tumours. Lyon: IARC; 2005. p. 140.
131. Kambič V, Gale N. Epithelial hyperplastic lesions of the larynx. Amsterdam: Elsevier; 1995.
132. Cardesa A, Slootweg PJ, editors. Pathology of the head and neck. Berlin: Springer, 2006.
133. Cardesa A, Mentzel T, Rudolph P, Slootweg PJ, editors. Pathologie: Kopf-Hals-Region, Weichgewebstumoren, Haut. G Köppel, HH Kreipe, W Remmele (series eds.). Founded by W Remmele, 3rd ed. Berlin: Springer; 2009.
134. Hellquist H, Cardesa A, Gale N, Kambic V, Michaels L. Criteria for grading in the Ljubljana classification of epithelial hyperplastic laryngeal lesions. A study by members of the working group on epithelial hyperplastic laryngeal lesions of the European Society of Pathology. Histopathology. 1999;34:226.
135. Gale N, Kambic V, Michaels L, Cardesa A, et al. The Ljubljana classification: a practical strategy for the diagnosis of laryngeal precancerous lesions. Adv Anat Pathol. 2000;7:240.
136. Luzar B, Poljak M, Marin IJ, Fischinger J, Gale N. Quantitative measurement of telomerase catalytic subunit (hTERT) mRNA in laryngeal squamous cell carcinomas. Anticancer Res. 2001;21:4011.
137. Luzar B, Poljak M, Marin IJ, Gale N. Telomerase reactivation is an early event in laryngeal carcinogenesis. Mod Pathol. 2003;16:841.
138. Gale N, Michaels L, Luzar B, et al. Current review on squamous intraepithelial lesions of the larynx. Histopathology 2009;54:639.
139. Kim MM, Clinger JD, Masayesva BG, et al. Mitochondrial DNA quantity increases with histopathological grade in premalignant and malignant head and neck lesions. Clin Cancer Res. 2004;10:8512.
140. Wells M, Östör AG, Crum CP, et al. Tumours of uterine cervix: epithelial tumours. In: Tavassoli FA, Devilee P, editors. WHO classification: tumours of the breast and female genital organs. Lyon: IARC; 2003. p. 262.